Neptune Technologies & Bioressources Inc. (Neptune) is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and NeuroBioPharmInc. The Neptune segment produces and commercializes nutraceutical products. The Company’s Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. The Company’s NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. The Company’s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO) which come in capsule form and serve as a dietary supplement to consumers.